683 Capital Management’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

683 Capital Management’s Portfolio ONTXW Stock Details ONTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-922,550	Closed	-$1.37M	–	198
2018 Q3	$1.37M	Buy	+922,550	New	+$148K	0.09%	93
2018 Q2	–	Sell	-2,000,000	Closed	-$172K	–	165
2018 Q1	$172K	Buy	+2,000,000	New	+$749K	0.02%	121

Other funds holding ONTXW

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

683 Capital Management's ONTXW Position: Q4 2018 in Review

683 Capital Management sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q4 2018, closing a stake of 922,550 shares — an estimated $1.37M sold.

683 Capital Management first reported a position in ONTXW in Q1 2018 and held it in 2 quarters. The position peaked at $1.37M in Q3 2018. 4 funds tracked by Wall St. Rank hold ONTXW as of Q4 2018.

683 Capital Management reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q4 2018 after selling out during the quarter.
683 Capital Management sold 922,550 Onconova Therapeutics, Inc. Warrants shares in Q4 2018, an estimated $1.37M.
683 Capital Management first reported a position in Onconova Therapeutics, Inc. Warrants in Q1 2018 and held it in 2 quarters.
683 Capital Management's Onconova Therapeutics, Inc. Warrants position peaked at $1.37M in Q3 2018.
4 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q4 2018.

Based on 683 Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.